NEOPLASMS, COLON
Clinical trials for NEOPLASMS, COLON explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLON trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in early colon cancer trial
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug dostarlimab to standard chemotherapy (CAPEOX) before surgery works better than chemotherapy alone for a common type of colon cancer (MMRp/MSS). About 120 people with stage III or T4N0 colon cancer that has not been treated ye…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a single drug replace chemo for some colon cancers?
Disease control Recruiting nowThis phase 3 trial tests the immunotherapy drug dostarlimab against standard chemotherapy in 892 people with a specific type of colon cancer (dMMR/MSI-H) that has not spread. The goal is to see if dostarlimab alone can prevent cancer from coming back or causing death. Participant…
Matched conditions: NEOPLASMS, COLON
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC